Xu Xing Lu
Director/Board Member at Zhejiang Test Bio-Tech Co. Ltd.
Xu Xing Lu active positions
Companies | Position | Start | End |
---|---|---|---|
Zhejiang Test Bio-Tech Co. Ltd.
Zhejiang Test Bio-Tech Co. Ltd. Medical SpecialtiesHealth Technology Zhejiang Test Bio-Tech Co. Ltd. manufactures and distributes in vitro diagnostic reagents. It engages in clinical biochemical diagnostic reagents, immune diagnostic reagents, molecular diagnostic reagents and other new type of in vitro diagnostic reagents R&D, production and sales service. The company was founded in 2011 and is headquartered in Shaoxing, China. | Director/Board Member | - | - |
Shanghai Xingaofeng Biological Medicine Co., Ltd.
Shanghai Xingaofeng Biological Medicine Co., Ltd. BiotechnologyHealth Technology Part of Zhejiang Yatai Pharmaceutical Co., Ltd., Shanghai Xingaofeng Biological Medicine Co., Ltd. is a biotechnology company based in Shanghai, CN. Shanghai Xingaofeng Biological Medicine Co. was acquired by Zhejiang Yatai Pharmaceutical Co., Ltd. from Green Villa Holdings Ltd. on December 02, 2015 for $141.84 million. The Chinese company engages in the development of biotechnology. The company was founded in 2007. The CEO is Li Yun Wang. | Director/Board Member | - | - |
Career history of Xu Xing Lu
Former positions of Xu Xing Lu
Companies | Position | Start | End |
---|---|---|---|
ZHEJIANG YATAI PHARMACEUTICAL CO., LTD. | Director/Board Member | 2013-12-19 | 2022-04-14 |
Chief Executive Officer | 2013-12-19 | 2017-05-15 | |
Chairman | 2010-12-10 | 2013-12-19 | |
Shanghai Newsummit Biopharma Group Co., Ltd.
Shanghai Newsummit Biopharma Group Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Newsummit Biopharma Group Co., Ltd. provides new drug development process solutions. Its services include pre-clinical development, clinical development, and assistance in the preparation of the regulatory submission of investigational new drug and new drug applications. The company also involves in the provision of technical services for medical devices research. Shanghai Newsummit Biopharma Group was founded by Jun Ren in 2001 and is headquartered in Shanghai, China. | Director/Board Member | - | - |
Statistics
International
China | 5 |
Operational
Director/Board Member | 4 |
Chief Executive Officer | 1 |
Chairman | 1 |
Sectoral
Health Technology | 4 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
ZHEJIANG YATAI PHARMACEUTICAL CO., LTD. | Health Technology |
Private companies | 3 |
---|---|
Zhejiang Test Bio-Tech Co. Ltd.
Zhejiang Test Bio-Tech Co. Ltd. Medical SpecialtiesHealth Technology Zhejiang Test Bio-Tech Co. Ltd. manufactures and distributes in vitro diagnostic reagents. It engages in clinical biochemical diagnostic reagents, immune diagnostic reagents, molecular diagnostic reagents and other new type of in vitro diagnostic reagents R&D, production and sales service. The company was founded in 2011 and is headquartered in Shaoxing, China. | Health Technology |
Shanghai Newsummit Biopharma Group Co., Ltd.
Shanghai Newsummit Biopharma Group Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Newsummit Biopharma Group Co., Ltd. provides new drug development process solutions. Its services include pre-clinical development, clinical development, and assistance in the preparation of the regulatory submission of investigational new drug and new drug applications. The company also involves in the provision of technical services for medical devices research. Shanghai Newsummit Biopharma Group was founded by Jun Ren in 2001 and is headquartered in Shanghai, China. | Commercial Services |
Shanghai Xingaofeng Biological Medicine Co., Ltd.
Shanghai Xingaofeng Biological Medicine Co., Ltd. BiotechnologyHealth Technology Part of Zhejiang Yatai Pharmaceutical Co., Ltd., Shanghai Xingaofeng Biological Medicine Co., Ltd. is a biotechnology company based in Shanghai, CN. Shanghai Xingaofeng Biological Medicine Co. was acquired by Zhejiang Yatai Pharmaceutical Co., Ltd. from Green Villa Holdings Ltd. on December 02, 2015 for $141.84 million. The Chinese company engages in the development of biotechnology. The company was founded in 2007. The CEO is Li Yun Wang. | Health Technology |
- Stock Market
- Insiders
- Xu Xing Lu
- Experience